Supriya Lifescience P/E Ratio
Current P/E Ratio
39.95
High Valuation
Very High - High growth expectations or significantly overvalued
Supriya Lifescience P/E ratio. Supriya Lifescience (SUPRIYA) P/E ratio is 39.95 (High), EPS (TTM) ₹25.98, current price ₹899.55 on NSE — Very High - High growth expectations or significantly overvalued. Check Supriya Lifescience market worth to track the company's total market size over time.
Current Valuation Metrics
P/E Ratio
39.95
Current Price
₹899.55
EPS (TTM)
₹25.98
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
56.41
Sector Median
31.61
Sector Rank
#11 of 199
Sector Percentile
5.5%
SUPRIYA P/E Ratio — Valuation Signal & Historical Context
Supriya Lifescience P/E 39.95 — signal: Overvalued. Also explore SUPRIYA share price history to track price trends across different timeframes.
- Stock appears overvalued with PE of 39.95, suggesting caution for new investments
- Trading at discount to sector average PE of 56.41
SUPRIYA vs Healthcare Peers — P/E Ratio Comparison
Supriya Lifescience P/E 39.95 vs Healthcare average 56.41, median 31.61 — range 2.04–740.29.
Sector Average
56.41
Sector Median
31.61
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 2.04 | ₹65 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹63 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.29 | ₹6,582 | Low |
| Dipna Pharmachem | DPL | 4.57 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.88 | ₹66 | Low |
| Kabra Drugs | KABRADG | 6.09 | ₹44 | Low |
| GKB Ophthalmics | GKB | 6.27 | ₹33 | Low |
| Royal Sense | ROYAL | 6.58 | ₹47 | Low |
| Colinz Laboratories | COLINZ | 6.62 | ₹18 | Low |